FDA drug approvals
Every approval of a new drug, generic or biologic by the US Food and Drug Administration, newest first, under the company that holds the application today, from Drugs@FDA. 25,670 approvals on file, 13,159 held by companies on value.today.
Approvals, 2026
724
all applicants
50
New uses approved, 2026
196
efficacy supplements
Approvals, 2025
824
50 new molecules
FDA approvals: new molecular entities
1,870 approvals, newest first.
| Approved | Drug | Held by | Kind |
|---|---|---|---|
| 2026-11-13 | Klygefanew moleculeGefurulimab · Solution · Injection · BLA761488 | 🇺🇸 Alexion Pharmaceuticals, Inc. | Biologic (BLA) |
| 2026-11-10 | Pimjetminew moleculePimicotinib · Capsule · Oral · NDA220414 | 🇩🇪 Merck KGaA | New drug (NDA) |
| 2026-11-09 | Sunharbonew moleculepriority reviewAsundexian · Tablet · Film Coated · NDA221291 | 🇩🇪 Bayer AG | New drug (NDA) |
| 2026-10-20 | Hibsagonew moleculepriority reviewBepirovirsen · Injection · Solution · NDA221276 | 🇬🇧 GSK plc | New drug (NDA) |
| 2026-10-09 | Hovilprinew moleculepriority reviewPritelivir Mesylate · Tablet · Oral · NDA221154 | AICURIS ANTI-INFECT | New drug (NDA) |
| 2026-09-28 | Emcitatenew moleculepriority reviewTiratricol · Tablet, For Suspension · Oral · NDA220963 | RARE THYROID | New drug (NDA) |
| 2026-09-25 | Juvmo, Juvmo (Copackaged)new moleculeTavapadon · Tablet · Oral · NDA220415 | 🇺🇸 AbbVie Inc. | New drug (NDA) |
| 2026-09-25 | Atebrioznew moleculepriority reviewZilurgisertib Fumarate · Tablet · Oral · NDA221198 | 🇺🇸 Mirum Pharmaceuticals, Inc. | New drug (NDA) |
| 2026-09-23 | Onswiknew moleculeInsulin Efsitora Alfa-Gobe · Injectable · Subcutaneous · BLA761408 | 🇺🇸 Eli Lilly and Company | Biologic (BLA) |
| 2026-09-23 | Lyrfigtunew moleculepriority reviewLirafugratinib Hydrochloride · Capsule · Oral · NDA220425 | ELEVAR | New drug (NDA) |
| 2026-09-11 | Isembyldnew moleculepriority reviewApitegromab-Mstn · Injectable · Injection · BLA761463 | 🇺🇸 Scholar Rock Holding Corporation | Biologic (BLA) |
| 2026-09-11 | Pixclaranew moleculepriority reviewFloretyrosine F-18 · Solution · Intravenous · NDA218592 | 🇦🇺 Telix Pharmaceuticals Limited | New drug (NDA) |
| 2026-09-04 | Etcamahnew moleculeCamizestrant · Tablet · Oral · NDA220359 | 🇬🇧 AstraZeneca PLC | New drug (NDA) |
| 2026-09-03 | Zanvastronew moleculepriority reviewZilganersen Sodium · Solution · Intrathecal · NDA220210 | 🇺🇸 Ionis Pharmaceuticals, Inc. | New drug (NDA) |
| 2026-08-28 | Mimrylonew moleculepriority reviewRusfertide Acetate · Powder · Subcutaneous · NDA220605 | TAKEDA PHARMS AM | New drug (NDA) |
| 2026-08-27 | Lisrayanew moleculepriority reviewBrepocitinib Tosylate · Tablet · Oral · NDA220106 | PRIOVANT THERAP | New drug (NDA) |
| 2026-08-26 | Rasonquenew moleculepriority reviewDaraxonrasib · Tablet · Oral · NDA220910 | 🇺🇸 Revolution Medicines, Inc. | New drug (NDA) |
| 2026-08-19 | Pasatrunew moleculepriority reviewGaretosmab-Grts · Injectable · Intravenous · BLA761508 | 🇺🇸 Regeneron Pharmaceuticals, Inc. | Biologic (BLA) |
| 2026-08-13 | Tauklarifynew moleculeFlorquinitau F-18 · Solution · Intravenous · NDA220496 | CERVEAU LANTHEUS | New drug (NDA) |
| 2026-08-13 | Zenbexusnew moleculepriority reviewIberdomide Hydrochloride · Capsule · Oral · NDA221075 | 🇺🇸 Bristol-Myers Squibb Company | New drug (NDA) |
| 2026-08-05 | Orzeyfulnew moleculepriority reviewOveporexton · Tablet · Oral · NDA220860 | 🇯🇵 Takeda Pharmaceutical Company Limited | New drug (NDA) |
| 2026-07-24 | Lytenavanew moleculeBevacizumab-Vikg · Vial · Single-Dose · BLA761320 | 🇺🇸 Outlook Therapeutics, Inc. | Biologic (BLA) |
| 2026-07-24 | Simtriyonew moleculepriority reviewCentanafadine Hydrochloride · Capsule, Extended Release · NDA218145 | 🇯🇵 Otsuka Holdings Co., Ltd. | New drug (NDA) |
| 2026-07-22 | Jideytronew moleculeZidesamtinib · Tablet · Oral · NDA220185 | 🇺🇸 Nuvalent, Inc. | New drug (NDA) |
| 2026-07-15 | Lipfendranew moleculepriority reviewEnlicitide Decanoate · Tablet · Oral · NDA220848 | MSD | New drug (NDA) |
| 2026-07-14 | Revtorpyknew moleculepriority reviewGedatolisib · Powder · Intravenous · NDA219908 | 🇺🇸 Celcuity Inc. | New drug (NDA) |
| 2026-07-07 | Trutaknanew moleculepriority reviewAtacicept-Vymj · Injectable · Subcutaneous · BLA761486 | 🇺🇸 Vera Therapeutics, Inc. | Biologic (BLA) |
| 2026-06-26 | Lumvoanew moleculepriority reviewVeligrotug-Vvze · Injection · BLA761530 | 🇺🇸 Viridian Therapeutics, Inc. | Biologic (BLA) |
| 2026-06-17 | Utebzinew moleculepriority reviewTebipenem Pivoxil Hydrobromide · Tablet · Oral · NDA215960 | 🇬🇧 GSK plc | New drug (NDA) |
| 2026-06-12 | Ambelvistnew moleculeGadoquatrane · Solution · Intravenous · NDA219627 | 🇩🇪 Bayer AG | New drug (NDA) |
| 2026-05-29 | Xocovanew moleculeEnsitrelvir · Tablet · Oral · NDA220442 | 🇯🇵 Shionogi & Co., Ltd. | New drug (NDA) |
| 2026-05-29 | Cypsedonew moleculeCipepofol · Emulsion · Intravenous · NDA220482 | 🇨🇳 Haisco Pharmaceutical Group Co., Ltd. | New drug (NDA) |
| 2026-05-29 | Zaynichnew moleculepriority reviewCefepime Hydrochloride, Zidebactam · Powder · Intravenous · NDA220787 | WOCKHARDT BIO AG | New drug (NDA) |
| 2026-05-27 | Decnupaznew moleculepriority reviewPivekimab Sunirine-Pvzy · Vial · Single-Dose · BLA761460 | 🇺🇸 AbbVie Inc. | Biologic (BLA) |
| 2026-05-22 | Hepcludexnew moleculepriority reviewBulevirtide-Gmod · Injection · Powder,For Solution · BLA761468 | 🇺🇸 Gilead Sciences, Inc. | Biologic (BLA) |
| 2026-05-15 | Baxfendynew moleculepriority reviewBaxdrostat · Tablet · Oral · NDA219878 | 🇬🇧 AstraZeneca PLC | New drug (NDA) |
| 2026-05-13 | Beqalzinew moleculepriority reviewSonrotoclax · Tablet · Oral · NDA220711 | BEONE MEDICINES USA | New drug (NDA) |
| 2026-05-01 | Veppanunew moleculeVepdegestrant · Tablet · Oral · NDA219835 | 🇺🇸 Rigel Pharmaceuticals, Inc. | New drug (NDA) |
| 2026-04-20 | Idvynsonew moleculeDoravirine, Islatravir · Tablet · Oral · NDA216964 | MSD | New drug (NDA) |
| 2026-04-01 | Foundayonew moleculeOrforglipron Calcium · Tablet · Oral · NDA220934 | 🇺🇸 Eli Lilly and Company | New drug (NDA) |
| 2026-03-26 | Awiqli Flextouchnew moleculeInsulin Icodec · Injection · Solution · BLA761326 | 🇩🇰 Novo Nordisk A/S | Biologic (BLA) |
| 2026-03-25 | Lifyorli (Copackaged)new moleculeRelacorilant · Capsule · Oral · NDA220641 | CORCEPT THERAP | New drug (NDA) |
| 2026-03-24 | Avlayahnew moleculepriority reviewTividenofusp Alfa-Eknm · Injection · Powder,For Solution · BLA761485 | 🇺🇸 Denali Therapeutics Inc. | Biologic (BLA) |
| 2026-03-17 | Icotydenew moleculepriority reviewIcotrokinra Hydrochloride · Tablet · Oral · NDA220149 | 🇺🇸 Johnson & Johnson | New drug (NDA) |
| 2026-03-17 | Lynavoynew moleculeLinerixibat · Tablet · Oral · NDA220295 | 🇺🇸 Intercept Pharmaceuticals | New drug (NDA) |
| 2026-02-27 | Yuviwelnew moleculepriority reviewNavepegritide · Powder · Subcutaneous · NDA219164 | ASCENDIS | New drug (NDA) |
| 2026-02-23 | Loargysnew moleculepriority reviewPegzilarginase-Nbln · Injectable · Injection · BLA761211 | IMMEDICA PHARMA AB | Biologic (BLA) |
| 2026-02-20 | Bysantinew moleculeMilsaperidone · Tablet · Oral · NDA220358 | 🇺🇸 Vanda Pharmaceuticals Inc. | New drug (NDA) |
| 2026-02-12 | Adqueynew moleculeDifamilast · Ointment · Topical · NDA219474 | ACROTECH BIOPHARMA | New drug (NDA) |
| 2026-01-12 | Zycubonew moleculepriority reviewCopper Histidinate · Powder · Subcutaneous · NDA211241 | SENTYNL THERAPS INC | New drug (NDA) |
Most approvals, last 12 months
Companies on value.today.
Source: US Food and Drug Administration, Drugs@FDA (openFDA) · as of Nov 13, 2026. Approvals follow the application to its current holder, so an acquired company's approvals appear under the buyer. Vaccines and blood products are approved by another FDA centre and are not listed. How it is counted